The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CELGENE CORPORATION | COM | 151020904 | 34,346 | 385,000 | SH | Call | SOLE | 385,000 | 0 | 0 | |
| FIBROGEN INC | COM | 31572Q908 | 15,015 | 325,000 | SH | Call | SOLE | 325,000 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X908 | 7,771 | 503,600 | SH | Call | SOLE | 503,600 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X908 | 2,534 | 164,200 | SH | Call | SOLE | 164,200 | 0 | 0 | |
| NEWLINK GENETICS CORP | COM | 651511907 | 4,060 | 560,000 | SH | Call | SOLE | 560,000 | 0 | 0 | |
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 13,573 | 3,668,307 | SH | SOLE | 3,668,307 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS ORD | COM | 00847X104 | 14,144 | 172,952 | SH | SOLE | 172,952 | 0 | 0 | ||
| AKEBIA THERAPEUTICS ORD | COM | 00972D105 | 13,580 | 1,425,000 | SH | SOLE | 1,425,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 23,356 | 1,056,348 | SH | SOLE | 1,056,348 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | COM | 04269X105 | 49,765 | 3,049,312 | SH | SOLE | 3,049,312 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 144,627 | 2,943,165 | SH | SOLE | 2,943,165 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 5,416 | 469,700 | SH | SOLE | 469,700 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 6,399 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| DOVA PHARMACEUTICALS ORD | COM | 25985T102 | 11,654 | 429,729 | SH | SOLE | 429,729 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS ORD | COM | 253031108 | 45,548 | 4,764,447 | SH | SOLE | 4,764,447 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 92,513 | 2,002,437 | SH | SOLE | 2,002,437 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS ORD | COM | 33830X104 | 21,311 | 1,240,470 | SH | SOLE | 1,240,470 | 0 | 0 | ||
| GERON ORD | COM | 374163103 | 1,488 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| IMMUNE DESIGN CORP | COM | 45252L103 | 14,422 | 4,437,600 | SH | SOLE | 4,437,600 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 90,815 | 5,885,583 | SH | SOLE | 5,885,583 | 0 | 0 | ||
| KINDRED BIOSCIENCES INC | COM | 494577109 | 2,151 | 248,680 | SH | SOLE | 248,680 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 70,628 | 3,766,852 | SH | SOLE | 3,766,852 | 0 | 0 | ||
| ATYR PHARMA INC | COM | 002120103 | 10,579 | 3,917,972 | SH | SOLE | 3,917,972 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 36,497 | 1,450,606 | SH | SOLE | 1,450,606 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS ORD | COM | 74366E102 | 9,308 | 1,083,567 | SH | SOLE | 1,083,567 | 0 | 0 | ||
| ARCUS BIOSCIENCES ORD | COM | 03969F109 | 34,530 | 2,236,387 | SH | SOLE | 2,236,387 | 0 | 0 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 6,339 | 318,564 | SH | SOLE | 318,564 | 0 | 0 | ||
| SYNLOGIC ORD | COM | 87166L100 | 6,566 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| UROGEN PHARMA ORD | COM | M96088105 | 19,990 | 402,300 | SH | SOLE | 402,300 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | COM | Y95308105 | 58,509 | 1,459,072 | SH | SOLE | 1,459,072 | 0 | 0 | ||
| ASCENDIS PHARMA | SPONSORED ADR | 04351P101 | 119,196 | 1,822,575 | SH | SOLE | 1,822,575 | 0 | 0 | ||
| DBV TECHNOLOGIES ADR REP 0.5 ORD | SPONSORED ADR | 23306J101 | 10,382 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||